Preconceived notions about biosimilars—a French experience-Reference-Cited by-同舟云学术

Preconceived notions about biosimilars—a French experience

Published:2020-06-22 Issue:8 Volume:39 Page:2251-2254
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Cohen Jean-David^ORCID,Tropé Sonia,Paubel Pascal,Munos Audrey,Bocquet François

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-020-05229-7.pdf

Reference22 articles.

1. Vezér B, Buzás Z, Sebeszta M, Zrubka Z (2016) Authorized manufacturing changes for therapeutic monoclonal antibodies (mAbs) in European Public Assessment Report (EPAR) documents. Curr Med Res Opin 32:829–834

2. Kay J, Schoels MM, Dörner T, Emery P, Kvien TK, Smolen JS, Breedveld FC (2018) Task force on the use of biosimilars to treat rheumatological diseases. consensus-based recommendations for the use of biosimilars to treat rheumatological diseases. Ann Rheum Dis 77:165–174

3. Beck M, Michel B, Rybarczyk-Vigouret MC, Levêque D, Sordet C, Sibilia J et al (2016) Rheumatologists' perceptions of biosimilar medicines prescription: findings from a French web-based survey. BioDrugs 30:585–592

4. Armuzzi A, Avedano L, Greveson K, Kang T (2019) Nurses are critical in aiding patients transitioning to biosimilars in inflammatory bowel disease: education and communication strategies. J Crohns Colitis 13:259–266

5. European Charter of Patients’Right (2002). http://www.activecitizenship.net/patients-rights/projects/29-european-charter-of-patients-rights.html. Accessed 1 July 2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain;BioDrugs;2024-02-26